Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
2.200
+0.200 (10.00%)
At close: Jan 9, 2026, 4:00 PM EST
2.320
+0.120 (5.45%)
After-hours: Jan 9, 2026, 7:59 PM EST
Genprex Market Cap
Genprex has a market cap or net worth of $5.1 million as of January 9, 2026. Its market cap has decreased by -35.79% in one year.
Market Cap
5.10M
Enterprise Value
4.00M
1-Year Change
-35.79%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $5.10M, a decrease of -91.67%. That is a compound annual growth rate of -27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 5.10M | 25.71% |
| Dec 31, 2025 | 4.06M | -43.99% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.53B |
| Johnson & Johnson | 494.19B |
| AbbVie | 395.24B |
| UnitedHealth Group | 314.73B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.11B |
| Merck & Co. | 271.83B |
| Novo Nordisk | 254.60B |